At the San Antonio Breast Cancer Symposium in San Antonio, Thomas P. Slavin Jr., MD, MBA, FACMGG, DABMD, discussed in this Q&A with Pharmacy Times how rising cancer incidence among younger adults is accelerating the integration of precision…
Advancing Precision Oncology: Pharmacist Perspectives on MRD Testing and Diagnostic Innovation
